06/20/2026
Thank you to everyone who joined the Seaver Autism Center’s 30th Annual Advances in Autism Conference: Precision Therapeutics in Profound Autism. Attendees heard how international studies led by Joseph D. Buxbaum, PhD, MSc, Director of the Seaver Autism Center, have identified more than 250 genes that strongly contribute to autism, helping researchers better understand genetically distinct subtypes of the condition. These discoveries are paving the way for more personalized treatments and a future where autism care can be tailored to an individual’s unique biology.